Novo Nordisk
NVO
NVO
659 hedge funds and large institutions have $9.35B invested in Novo Nordisk in 2020 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 193 increasing their positions, 270 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.13% less ownership
Funds ownership: 16.96% → 15.83% (-1.1%)
24% less funds holding in top 10
Funds holding in top 10: 21 → 16 (-5)
29% less repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 270
Holders
659
Holding in Top 10
16
Calls
$79.4M
Puts
$32.5M
Top Buyers
| 1 | +$170M | |
| 2 | +$55.6M | |
| 3 | +$54.9M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$47.5M |
| 5 |
Two Sigma Investments
New York
|
+$24.6M |
Top Sellers
| 1 | -$594M | |
| 2 | -$169M | |
| 3 | -$82.9M | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$75.2M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$54.1M |